In: mRNA

  1. Home
  2. News
Check out our new article: ‘Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity’ – OPEN ACCESS
August 19, 2024

Publication: Mireya L. Borrajo, Aloia Quijano, Philipp Lapuhs, Ana I. Rodriguez-Perez, Shubaash Anthiya, José L. Labandeira-Garcia, Rita Valenzuela, María José Alonso, Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity, Journal of Controlled Release, Volume 372, 2024, Pages 295-303, ISSN 0168-3659, https://doi.org/10.1016/j.jconrel.2024.06.051

Read More
María José Alonso, elected Secretary of the Controlled Release Society
María José Alonso leads a USC project aimed at developing a new vaccine against COVID-19 based on mRNA
May 11, 2020

Developing and evaluating in preclinical studies a new vaccine based on mRNA against SARS-CoV2 capable of inducing long-term immune responses against the virus is the ultimate goal of the research project in which the laboratory led by María José Alonso participates together with the group led by Mabel Loza, both at CiMUS and FIDIS – University of Santiago de Compostela (USC). The objective of the USC laboratories is to produce a synthetic vehicle based on innocuous biomaterials, capable of transporting the mRNA into the target cells and enabling the production of the antigen in the human body.

Read More
Get free access to our paper: “mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering”
April 22, 2020

Publication: Adriana M. Ledo, Ana Senra, Héctor Rilo-Álvarez, Erea Borrajo, Anxo Vidal, María J. Alonso, Marcos García-Fuentes, RNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering, Biomaterials, Vol. 247, July 2020 https://doi.org/10.1016/j.biomaterials.2020.120016. Free Access until May 26

Read More